Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vena Cava Filters | 8 | 2025 | 92 | 1.080 |
Why?
|
| Students, Medical | 2 | 2020 | 449 | 0.840 |
Why?
|
| Carcinoma, Hepatocellular | 6 | 2026 | 450 | 0.830 |
Why?
|
| Device Removal | 7 | 2025 | 170 | 0.810 |
Why?
|
| Embolization, Therapeutic | 6 | 2025 | 320 | 0.800 |
Why?
|
| Vena Cava, Inferior | 7 | 2020 | 140 | 0.790 |
Why?
|
| Liver Neoplasms | 6 | 2026 | 831 | 0.700 |
Why?
|
| Career Choice | 2 | 2020 | 161 | 0.660 |
Why?
|
| Medicine | 1 | 2020 | 95 | 0.590 |
Why?
|
| Pulmonary Embolism | 4 | 2025 | 234 | 0.480 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 601 | 0.420 |
Why?
|
| Chemoembolization, Therapeutic | 2 | 2026 | 41 | 0.410 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 685 | 0.410 |
Why?
|
| Prosthesis Implantation | 3 | 2020 | 134 | 0.400 |
Why?
|
| Radiology, Interventional | 3 | 2021 | 62 | 0.350 |
Why?
|
| Yttrium Radioisotopes | 4 | 2026 | 57 | 0.320 |
Why?
|
| Renal Dialysis | 3 | 2021 | 357 | 0.310 |
Why?
|
| Radiography, Interventional | 5 | 2020 | 157 | 0.310 |
Why?
|
| Arteriovenous Fistula | 2 | 2021 | 57 | 0.300 |
Why?
|
| Tumor Burden | 3 | 2026 | 333 | 0.290 |
Why?
|
| Microwaves | 2 | 2026 | 45 | 0.280 |
Why?
|
| Treatment Outcome | 18 | 2026 | 9708 | 0.280 |
Why?
|
| Catheter Ablation | 2 | 2022 | 381 | 0.260 |
Why?
|
| Venous Thrombosis | 2 | 2025 | 264 | 0.260 |
Why?
|
| Angioplasty | 2 | 2019 | 68 | 0.240 |
Why?
|
| Radiopharmaceuticals | 2 | 2026 | 217 | 0.240 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2021 | 244 | 0.230 |
Why?
|
| Ablation Techniques | 1 | 2026 | 52 | 0.230 |
Why?
|
| Angiography | 3 | 2021 | 194 | 0.230 |
Why?
|
| Ultrasonography, Interventional | 2 | 2024 | 126 | 0.220 |
Why?
|
| Time Factors | 9 | 2026 | 5567 | 0.210 |
Why?
|
| Arteriovenous Malformations | 1 | 2025 | 55 | 0.210 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2024 | 44 | 0.210 |
Why?
|
| Computed Tomography Angiography | 3 | 2021 | 188 | 0.200 |
Why?
|
| Cholangiocarcinoma | 1 | 2024 | 83 | 0.200 |
Why?
|
| Microspheres | 1 | 2024 | 91 | 0.200 |
Why?
|
| Bile Duct Neoplasms | 1 | 2024 | 96 | 0.200 |
Why?
|
| Pulmonary Veins | 1 | 2025 | 118 | 0.200 |
Why?
|
| Hepatectomy | 1 | 2024 | 203 | 0.190 |
Why?
|
| Pulmonary Artery | 1 | 2025 | 342 | 0.190 |
Why?
|
| Humans | 30 | 2026 | 98053 | 0.180 |
Why?
|
| Retrospective Studies | 13 | 2026 | 10960 | 0.180 |
Why?
|
| Female | 19 | 2026 | 51525 | 0.180 |
Why?
|
| Workload | 2 | 2020 | 130 | 0.180 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 2021 | 10 | 0.170 |
Why?
|
| Hemostasis, Endoscopic | 1 | 2021 | 16 | 0.170 |
Why?
|
| Brachiocephalic Veins | 1 | 2021 | 31 | 0.170 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 3021 | 0.170 |
Why?
|
| Intensive Care Units | 1 | 2025 | 520 | 0.160 |
Why?
|
| Hospital Units | 1 | 2020 | 29 | 0.160 |
Why?
|
| Catheterization, Peripheral | 1 | 2021 | 62 | 0.160 |
Why?
|
| Radiology Department, Hospital | 1 | 2020 | 27 | 0.160 |
Why?
|
| Aneurysm, False | 1 | 2020 | 52 | 0.160 |
Why?
|
| Hepatic Artery | 1 | 2021 | 84 | 0.160 |
Why?
|
| Appointments and Schedules | 1 | 2020 | 60 | 0.160 |
Why?
|
| Radiology Information Systems | 1 | 2020 | 81 | 0.150 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 47 | 0.150 |
Why?
|
| Work-Life Balance | 1 | 2019 | 7 | 0.150 |
Why?
|
| Brachytherapy | 1 | 2021 | 139 | 0.150 |
Why?
|
| Middle Aged | 15 | 2026 | 29419 | 0.150 |
Why?
|
| Disease Progression | 1 | 2024 | 1610 | 0.150 |
Why?
|
| Risk Factors | 7 | 2025 | 6231 | 0.140 |
Why?
|
| Male | 16 | 2026 | 47062 | 0.140 |
Why?
|
| Sexism | 1 | 2019 | 64 | 0.140 |
Why?
|
| Mentors | 1 | 2019 | 103 | 0.140 |
Why?
|
| Aged | 13 | 2026 | 21750 | 0.140 |
Why?
|
| Social Media | 1 | 2020 | 118 | 0.130 |
Why?
|
| Medicare | 1 | 2021 | 466 | 0.130 |
Why?
|
| Hemorrhage | 1 | 2019 | 299 | 0.130 |
Why?
|
| Hemodynamics | 1 | 2021 | 747 | 0.130 |
Why?
|
| Motivation | 1 | 2020 | 343 | 0.130 |
Why?
|
| Computer Simulation | 1 | 2021 | 1147 | 0.120 |
Why?
|
| Fluoroscopy | 3 | 2024 | 138 | 0.120 |
Why?
|
| Aged, 80 and over | 7 | 2025 | 7386 | 0.120 |
Why?
|
| Societies, Medical | 1 | 2020 | 682 | 0.120 |
Why?
|
| Sex Factors | 1 | 2019 | 1138 | 0.120 |
Why?
|
| Mesenteric Arteries | 1 | 2015 | 29 | 0.110 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 467 | 0.110 |
Why?
|
| Prosthesis Design | 4 | 2019 | 308 | 0.110 |
Why?
|
| Stents | 2 | 2020 | 433 | 0.110 |
Why?
|
| Risk Assessment | 4 | 2025 | 2585 | 0.110 |
Why?
|
| Prosthesis Failure | 1 | 2014 | 117 | 0.100 |
Why?
|
| Catheters, Indwelling | 2 | 2013 | 102 | 0.090 |
Why?
|
| Postoperative Complications | 2 | 2015 | 2679 | 0.090 |
Why?
|
| Liver Transplantation | 2 | 2026 | 1235 | 0.090 |
Why?
|
| Catheterization, Central Venous | 2 | 2013 | 114 | 0.090 |
Why?
|
| Endoleak | 1 | 2012 | 45 | 0.090 |
Why?
|
| Hemostatics | 1 | 2012 | 64 | 0.090 |
Why?
|
| Young Adult | 5 | 2025 | 7504 | 0.080 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2012 | 125 | 0.080 |
Why?
|
| Adult | 8 | 2025 | 29529 | 0.070 |
Why?
|
| Chicago | 3 | 2019 | 1513 | 0.070 |
Why?
|
| Adolescent | 4 | 2025 | 10077 | 0.060 |
Why?
|
| Constriction, Pathologic | 2 | 2021 | 211 | 0.060 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 916 | 0.060 |
Why?
|
| Necrosis | 1 | 2026 | 212 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2009 | 445 | 0.050 |
Why?
|
| Phlebography | 2 | 2016 | 74 | 0.050 |
Why?
|
| SEER Program | 1 | 2024 | 243 | 0.050 |
Why?
|
| Operative Time | 1 | 2024 | 174 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2025 | 541 | 0.040 |
Why?
|
| Propensity Score | 1 | 2022 | 213 | 0.040 |
Why?
|
| Pulsatile Flow | 1 | 2021 | 50 | 0.040 |
Why?
|
| Brachial Artery | 1 | 2021 | 37 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 4025 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 2021 | 179 | 0.040 |
Why?
|
| Retreatment | 1 | 2021 | 107 | 0.040 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 55 | 0.040 |
Why?
|
| Mechanical Thrombolysis | 1 | 2020 | 18 | 0.040 |
Why?
|
| Angioplasty, Balloon | 1 | 2020 | 91 | 0.040 |
Why?
|
| Workflow | 1 | 2020 | 85 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2020 | 123 | 0.040 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2019 | 38 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 1945 | 0.040 |
Why?
|
| Hypotension | 1 | 2020 | 80 | 0.040 |
Why?
|
| Radiation Exposure | 1 | 2019 | 28 | 0.040 |
Why?
|
| United States | 2 | 2024 | 8192 | 0.040 |
Why?
|
| Contrast Media | 1 | 2024 | 1011 | 0.040 |
Why?
|
| Mortality | 1 | 2020 | 159 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2019 | 231 | 0.030 |
Why?
|
| Anesthesia, General | 1 | 2019 | 130 | 0.030 |
Why?
|
| Aspirin | 1 | 2019 | 169 | 0.030 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2020 | 161 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2021 | 2666 | 0.030 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 259 | 0.030 |
Why?
|
| Thrombectomy | 1 | 2020 | 260 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 2783 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 255 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2021 | 630 | 0.030 |
Why?
|
| Recurrence | 1 | 2020 | 1254 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 1012 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2020 | 486 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2015 | 174 | 0.030 |
Why?
|
| Models, Biological | 1 | 2021 | 1807 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 2013 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 1535 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2013 | 75 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 2041 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1777 | 0.020 |
Why?
|